News

As AI reshapes work, experts warn of mass layoffs, identity crises, and inequality. From UBI to job sharing, 9 urgent ...
The government would do well to reconsider the wisdom of actions that risk diluting the strategic clarity India needs, writes ...
The updated amounts are now calculated at 12.5% above the Low Income Cut-Off (LICO) and vary based on family size ...
"This report is baseless, inaccurate and misleading," said Adani Group, rejecting claims of a collaboration with Chinese ...
An Indian woman recently took to social media to share that she broke down in a meeting with her manager after she was forced ...
He warns that many Indian workers are dangerously exposed—not just because they’ve over-relied on their jobs, but because ...
Tata Investment reported a 11.61% rise in Q1 net profit at Rs 146.30 crore in Q1 against Rs 131.07 crore in the June 2024 ...
Saving for your kids' education is primarily to ensure you don't saddle them with debt when they start their careers, writes ...
India's E20 fuel aims for a greener future—but it may wreck engines not built for it. From lower mileage to warranty loss, ...
M&B Engineering sold its shares in the price band of Rs 366-385 apiece, which could be applied for a minimum of 38 shares and ...
Monsoon coughs and sniffles again? These herbal teas—from ginger to tulsi—may ease symptoms, boost immunity, and help you ...
Biocon and Aurobindo Pharma are identified as facing significant EPS impacts within the generics and biosimilars domain.